首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Oncology research and treatment

缩写:ONCOL RES TREAT

ISSN:2296-5270

e-ISSN:2296-5262

IF/分区:1.4/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引1067条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Hannah Dávid,Bernd Sonntag,Stephanie Stock et al. Hannah Dávid et al.
Introduction Communication training (CT) enhances the communication skills of oncology healthcare professionals. KPAP (Kommunikative Kompetenz und Performanz in der Arzt-Patient Beziehung fördern; fostering communicative competence and per...
Philipp Ivanyi,Bernd Alt-Epping,Lars Bullinger et al. Philipp Ivanyi et al.
Introduction: The introduction of immune checkpoint inhibitors (CPIs) in oncology has improved the long-term perspectives of many patients and is bringing the quality of life (QoL) into focus as a treatment-relevant varia...
Jing Yang,Xingzhen Cheng,Guo Wei et al. Jing Yang et al.
Background: Previous research indicates that combining antiviral and anti-tumor drugs may lead to compounded toxic side effects and risks of drug-drug interactions (DDIs). Our study aims to investigate the safety and effe...
Sabine Seiffert,André-René Blaudszun,Benjamin Shibru et al. Sabine Seiffert et al.
Due to the multifactorial nature of cancer, the development of reliable immunotherapies poses a significant challenge for medical research. In this context, targeting immune checkpoints holds promising potential. Natural killer (NK) cells a...
Mei Zhang,Junting Zhang,Guangyao Huang et al. Mei Zhang et al.
Backgroud: Tumor is a major public health problem worldwide and poses a serious threat to human life and health. Vitamin D deficiency increases the risk of developing tumors. ...
Marie-Elisabeth Leßmann,Christine Sibbert,Lea Reitnauer et al. Marie-Elisabeth Leßmann et al.
The European Society for Medical Oncology (ESMO) Congress 2024 presented pivotal new data across various trials that continue to explore the nuances of immunotherapy (ICI) in non-small-cell lung cancer (NSCLC) and small cell lung cancer (SC...
Thomas Hilser,Christopher Darr,Jens Bedke et al. Thomas Hilser et al.
Background: Urothelial carcinoma (UC) is a significant global health burden and shows consistent increase in incidence. The treatment landscape for advanced or metastatic urothelial carcinoma (mUC) has evolved, but signif...
Tana Takacova,Yashpal Singh,Adrian Seidel et al. Tana Takacova et al.
Paraneoplastic neurological syndromes are rare manifestations of cancer, characterized by auto-antibodies targeting neuronal antigens. These syndromes often precede or accompany cancer diagnosis, complicating their interpretation. In this c...
Hannes Hofbauer,Birgit Abberger,Nadia Kheirandish et al. Hannes Hofbauer et al.
Purpose Up to 40% of long-term cancer survivors suffer from chronic cancer-related pain (CCRP) with often inadequate treatment. CCRP is influenced by biopsychosocial factors, with interdisciplinary multimodal pain therapy (IMPT) being a com...
Pornpimon Nittiwatthanawit,Putsarat Insin Pornpimon Nittiwatthanawit
Introduction: Patients diagnosed with epithelial ovarian cancer (EOC) usually experience a poor prognosis with a 5-year survival rate of approximately 40%. Thus, there would be an interest in a new perspective on the anti...